• 2017 Lasker Awards For Basic And Clinical Medical Research

    Sep 6, 2017, 14:15 by Michael Croft

    Clinical Informatics News Brief | The Albert and Mary Lasker Foundation today announced the winners of the 2017 Lasker Awards: Michael N. Hall for basic medical research; and Douglas R. Lowy and John T. Schiller for clinical research.

    Full story
  • Drug Companies Need To Pay Patients For Clinical Trials

    Sep 6, 2017, 13:15 by Michael Croft
    TheHill |  If the goal is to bring more life-saving cancer treatments to market, or even find a cure, it's time for pharmaceutical companies to offer reimbursements.
    Full story
  • FormulationX To Debut At INTERPHEX 2018; Elsevier A Foundation Sponsor

    Sep 6, 2017, 05:18 by Michael Croft
    NEW YORK, NY - Sep 5, 2017 - International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, today announced FormulationX will debut at INTERPHEX 2018 featuring exhibits, technical conference and networking focused on drug substance
    Full story
  • Death Of First CAR-T Patient Forces Trial Halt For Cellectis

    Sep 5, 2017, 14:03 by Michael Croft
    ENDPOINTS NEWS |  The FDA has forced Cellectis to slam the brakes on two clinical trials of its off-the-shelf-version of a CAR-T therapy after their first patient was killed by a lethally toxic reaction to treatment.
    Full story
  • FDA Alerts on Risks From Merck’s Keytruda in Multiple Myeloma Following Halted Trials

    Aug 31, 2017, 11:38 by Michael Croft
    RAPS |  Today, FDA released an alert and summary findings from two halted Merck clinical trials evaluating the use of Keytruda (pembrolizumab) combined with other treatments in patients with multiple myeloma.
    Full story
  • Clinerion, Novartis, RxEOB, And More: News From August 2017

    Aug 31, 2017, 10:30 by Michael Croft

    Clinical Informatics News | August was full of exciting news in the clinical trial and healthcare community, including partnerships and products from Clinerion, Novartis, RxEOB, and more.

    Full story
  • TULA recognized by CIO Applications magazine as Top 25 GRC Technology Providers - 2017

    Aug 30, 2017, 07:33 by Michael Croft
    PRINCETON,NEW JERSEY, NJ, US - Aug 31, 2017 - In the wake of the growing need of GRC technology solutions across enterprises globally, CIO Applications has compiled a list of “Top 25 Governance, Risk, and Compliance Technology Providers 2017
    Full story
  • Survey Says: Subtle Shifts In Trial Startup Challenges

    Aug 29, 2017, 12:20 by Michael Croft

    Clinical Informatics News | A survey of 100, qualified respondents seeking insight into the trends in clinical trial patient enrollment and recruitment reveals subtle shifts in clinical trials startup challenges.

    Full story
  • Peter Thiel Funds 'Unethical' Offshore Herpes Vaccine Trial

    Aug 28, 2017, 09:02 by Michael Croft
    The Daily Beast |  The Trump adviser is part of a group of wealthy businessmen spending millions to test the vaccine on people-while evading Food and Drug Administration regulations.
    Full story
  • LifeSphere Intake and Triage™ Leverages Automation to Significantly Improve Efficiency of Safety Case Intake Process, Eliminating 90% of Manual Data Entry

    Aug 28, 2017, 06:00 by Michael Croft
    CHICAGO, IL, UNITED STATES - Aug 30, 2017 - ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences, announces LifeSphere Intake and Triage™, a sophisticated case triage solution that enables drug and device companies to manage the intake, receipt and triaging of adverse events (AEs) automatically from a wide range of sources, including email, fax, online portal, electronic gateway (capable of processing both E2B (R3) and E2B (R2) cases) and mobile apps
    Full story
  • Patients Not Always Informed Of Study's Purpose In Noninferiority Trials

    Aug 24, 2017, 15:04 by Michael Croft
    RAPS |  A study published in JAMA Internal Medicine this week finds that patients participating in noninferiority trials for antibiotics are not always accurately informed of the purpose of the study, based on an analysis of informed consent forms.
    Full story
  • Disrupting Clinical Operations With CRO Strategic Partnerships

    Aug 24, 2017, 09:35 by Michael Croft

    Clinical Informatics News Contributed Commentary | As the CRO industry adapts to be more budget minded and efficient, the quest for innovation remains. So, what does meaningful innovation look like for the clinical trial industry?

    Full story
  • Data Sharing: Stakeholder Perspectives On Transparency In Clinical Trials

    Aug 22, 2017, 10:20 by Michael Croft

    Clinical Informatics News Contributed Commentary | Calls for greater transparency and open data access in clinical research—with its promise to benefit researchers, innovation, and patients—continue actively. Providing access to individual patient data from other investigators, researchers, and the public creates new value in multiple areas.

    Full story
  • ArisGlobal Launches LifeSphere Clinical™ with New RTSM, eCOA and Clinical Payments Solutions, Offering the Most Comprehensive, Integrated Clinical Research Platform for Digital Health

    Aug 22, 2017, 00:47 by Michael Croft
    MIAMI, FL - Aug 23, 2017 - ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences announces LifeSphere Clinical™, the industry's first pre-validated, unified eClinical research platform for clinical operations and clinical data management
    Full story
  • Engineering The End Of Malaria

    Aug 21, 2017, 11:02 by Michael Croft
    Pacific Standard |  Intellectual Ventures has put some of the profits from licensing patents into developing breakthrough health-care technologies that nobody else has been able to pursue.
    Full story
  • Clinical Trials Need More Minorities In Them

    Aug 21, 2017, 09:39 by Michael Croft
    The Washington Post |  Minorities go underrepresented in important research efforts. Given the nation's changing demographics, it's neither good health policy nor good business to be developing drugs and possible cures that are tested in only a subset of the population.
    Full story
  • The Future Of Clinical Trial Protocols: Where Is The Industry Headed?

    Aug 18, 2017, 09:55 by Michael Croft

    Clinical Informatics News Contributed Commentary | The most important component of this process is the clinical trial protocol. Considerable time is spent trying to locate information and interpret the different ways critical protocol elements are described or defined. This sometimes lead to delays, errors, and sometimes both.

    Full story
  • TOP 100 Global Pharma company selected mIRT

    Aug 17, 2017, 09:02 by Michael Croft
    PRINCETON, NJ - Aug 17, 2017 - mIRT  was selected in Top 100 global pharma companies after considering 2 other vendor tools. Main reason for selection was the truly configurable "no-build" option mIRT offered which led to drastic start-up time, less testing resulting in deep savings overall
    Full story
  • FDA Expectations For Diversity Inclusion In Clinical Research

    Aug 15, 2017, 10:15 by Michael Croft

    Clinical Informatics News Contributed Commentary | FDA expects sponsors to enroll study participants who reflect the demographics of clinically relevant populations for their product with regard to age, sex, race, and ethnicity. In reality, however, current clinical trial populations do not reflect the true demographics and disease prevalence in the United States.

    Full story
  • WCG’s MedAvante-ProPhase Adds Business Leaders to Expand Offerings, Increase Client Success in CNS, Mental Health

    Aug 15, 2017, 09:57 by Michael Croft
    PRINCETON, NJ - Aug 15, 2017 - WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced today that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvante-ProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm
    Full story
  • «
  • 221
  • 222
  • 223
  • 224
  • 225
  • 226
  • 227 (current)
  • 228
  • 229
  • 230
  • »